Data / Form D filings / Illudent, Inc.
Illudent, Inc.: Form D filings
Illudent, Inc., a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on August 15, 2025, reports $3.2 million sold of a $4 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6181 CORNERSTONE COURT E, SUITE 104, San Diego, CA, 92121
- Phone
- (858) 761-7733
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1969039
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | New notice | $4,000,000 | $3,174,994 | $825,006 | 11 | Aug 12, 2025 | sec.gov |
| Oct 23, 2023 | Amendment | $1,199,999 | $1,199,995 | $4 | 16 | Mar 14, 2023 | sec.gov |
| Mar 17, 2023 | New notice | $1,199,999 | $599,999 | $600,000 | 2 | Mar 14, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael J. Kelner | Executive Officer, Director | |
| Joe J. Gatto | Executive Officer, Director | |
| Clint J. Korver | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Aug 11, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Illudent, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.